Summary Table: Endothelial / Vascular-Specific Promoters

Promoter	Target Cell Type	Size (bp)	Origin	Key Characteristics
VE-cadherin (CDH5)	Vascular Endothelium	~1.0–2.5 kb	Human / Mouse	One of the most specific promoters for mature endothelial cells. Low leakiness in other tissues.
Tie2 (Tek)	Endothelium / Angiogenesis	~0.8–2.1 kb	Mouse / Human	Essential for vascular development. Often paired with an enhancer (e.g., the Tie2 enhancer) to ensure high specificity.
KDR (VEGFR2)	Endothelial / Progenitors	~0.9–1.5 kb	Human	Vascular Endothelial Growth Factor Receptor 2. Highly active during vessel growth and in tumor vasculature.
ICAM2	Vascular Endothelium	~300 bp	Human	Intercellular Adhesion Molecule 2. Noted for its very small size, making it ideal for AAV-based vascular targeting.

Technical Insights for Vascular Vector Design

1. The ICAM2 Advantage for AAV While promoters like VE-cadherin provide high specificity, their large size can be a hurdle for AAV. The ICAM2 promoter is a favorite for viral vector engineers because it is only ~330 bp. Despite its small size, it remains highly restricted to the endothelium and is strong enough to drive therapeutic levels of transgene expression.

2. Tie2: Developmental and Angiogenic Targeting The Tie2 promoter is particularly useful when targeting “active” vasculature. It is highly expressed during embryonic development and in adults during wound healing or tumor-induced angiogenesis. In many vector designs, a “minimal” Tie2 promoter is combined with an intronic enhancer to ensure that expression is limited strictly to blood vessels and not hematopoietic stem cells (which also express native Tie2).

3. KDR for Cancer Gene Therapy KDR (VEGFR2) is often used in oncology because its activity is significantly upregulated in the leaky, rapidly growing vessels that feed tumors. By using a KDR-driven AAV or lentivirus, researchers can deliver “suicide genes” or toxins that selectively destroy the tumor’s blood supply while leaving healthy, quiescent vessels relatively unaffected.

4. Pan-Endothelial vs. Microvascular VE-cadherin is considered a “pan-endothelial” marker, meaning it is active in everything from large arteries to tiny capillaries. If your goal is broad vascular protection (e.g., after an organ transplant), VE-cadherin is the most reliable choice.